Baseline Requirements For Novel Agents Being Considered For Phase Ii/Iii Brain Cancer Efficacy Trials: Conclusions From The Adult Brain Tumor Consortium'S First Workshop On Cns Drug Delivery
NEURO-ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要